Scienture launches REZENOPY, cites patent wins and payer gains in Q2 2026 updateAug 20Quarterly updatenaloxoneScienture Holdings, Inc.
Emergent BioSolutions posts Q2 revenue surge but takes $191 million impairment, cuts 2026 outlookAug 5RestructuringEmergent BioSolutions
Sign inSign in